Looking to the next generation of obesity treatments, combinations of GLP-1 with other entero-pancreatic hormones with complementary actions and/or synergistic potential (such as glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin) are under investigation to enhance the WL and cardiometabolic benefits of GLP-1 RA
Anthem's CarelonRx covers it for the approved T2D indication with prior authorization
While Medicare plans are, since 2003, statutorily prevented from covering medications for weight loss, a bipartisan bill the Treat and Reduce Obesity Act (TROA) currently progressing through Congress seeks to repeal this law and enable coverage
Statements using words such as expect, anticipate, believe, may, will and similar terms are also forward-looking statements
Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study
By using Semaglutide GLP-1 injections, which work to reduce appetite and regulate blood sugar, Dr
